+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012

Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012

Mmwr. Morbidity and Mortality Weekly Report 64(47): 1305-1311

A high blood level of low-density lipoprotein cholesterol (LDL-C) remains a major risk factor for atherosclerotic cardiovascular disease (ASCVD), although data from 2005 through 2012 has shown a decline in high cholesterol (total and LDL cholesterol) along with an increase in the use of cholesterol-lowering medications. The most recent national guidelines (published in 2013) from the American College of Cardiology and the American Heart Association (ACC/AHA) expand previous recommendations for reducing cholesterol to include lifestyle modifications and medication use as part of complete cholesterol management and to lower risk for ASCVD. Because changes in cholesterol treatment guidelines might magnify existing disparities in care and medication use, it is important to describe persons currently eligible for treatment and medication use, particularly as more providers implement the 2013 ACC/AHA guidelines. To understand baseline estimates of U.S. adults on or eligible for cholesterol treatment, as well as to identify sex and racial/ethnic disparities, CDC analyzed data from the 2005-2012 National Health and Nutrition Examination Surveys (NHANES). Because the 2013 ACC/AHA guidelines focus on initiation or continuation of cholesterol treatment, adults meeting the guidelines' eligibility criteria as well as adults who were currently taking cholesterol-lowering medication were assessed as a group. Overall, 36.7% of U.S. adults or 78.1 million persons aged ≥21 years were on or eligible for cholesterol treatment. Within this group, 55.5% were currently taking cholesterol-lowering medication, and 46.6% reported making lifestyle modifications, such as exercising, dietary changes, or controlling their weight, to lower cholesterol; 37.1% reported making lifestyle modifications and taking medication, and 35.5% reported doing neither. Among adults on or eligible for cholesterol-lowering medication, the proportion taking cholesterol-lowering medication was higher for women than men and for non-Hispanic whites (whites) than Mexican-Americans and non-Hispanic blacks (blacks). Further efforts by clinicians and public health practitioners are needed to implement complementary and targeted patient education and disease management programs to reduce sex and racial/ethnic disparities among adults eligible for treatment of cholesterol.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 058615706

Download citation: RISBibTeXText

PMID: 26633047

Related references

Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012. Nchs Data Brief 2015(177): 1-8, 2015

Prevalence of cholesterol screening and high blood cholesterol among adults--United States, 2005, 2007, and 2009. Mmwr. Morbidity and Mortality Weekly Report 61: 697-702, 2012

Trends in lipid profiles and descriptive characteristics of U.S. adults with and without diabetes and cholesterol-lowering medication use-National Health and Nutrition Examination Survey, 2003-2012, United States. Plos One 13(3): E0193756, 2018

Current cigarette smoking among adults - United States, 2005-2012. Mmwr. Morbidity and Mortality Weekly Report 63(2): 29-34, 2014

Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200. Mmwr. Morbidity and Mortality Weekly Report 60(4): 109-114, 2011

Trends in food insecurity for adults with cardiometabolic disease in the United States: 2005-2012. Plos One 12(6): E0179172, 2017

Barriers to antihypertensive medication adherence among adults--United States, 2005. Journal of Clinical Hypertension 10(12): 922-929, 2008

Self-reported hypertension and use of antihypertensive medication among adults - United States, 2005-2009. Mmwr. Morbidity and Mortality Weekly Report 62(13): 237-244, 2013

Million hearts: prevalence of leading cardiovascular disease risk factors--United States, 2005-2012. Mmwr. Morbidity and Mortality Weekly Report 63(21): 462-467, 2014

Prevalence of obesity among adults: United States, 2011-2012. Nchs Data Brief 2014(131): 1-8, 2014

Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003. Mmwr. Morbidity and Mortality Weekly Report 54(34): 842-847, 2005

Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. JAMA Internal Medicine 176(4): 473-482, 2016

Prescription medication use among normal weight, overweight, and obese adults, United States, 2005-2008. Annals of Epidemiology 22(2): 112-119, 2012

Prevalence of and trends in diabetes among adults in the United States, 1988-2012. Journal of Diabetes 8(1): 8-9, 2016

Estimates of pain prevalence and severity in adults: United States, 2012. Journal of Pain 16(8): 769-780, 2015